Mammalian airways normally regulate the volume of a thin liquid layer, the periciliary liquid (PCL), to facilitate the mucus clearance component of lung defense. Studies under standard (static) culture conditions revealed that normal airway epithelia possess an adenosine-regulated pathway that blends Na ؉ absorption and Cl ؊ secretion to optimize PCL volume. In cystic fibrosis (CF), the absence of CF transmembrane conductance regulator results in a failure of adenosine regulation of PCL volume, which is predicted to initiate mucus stasis and infection. However, under conditions that mimic the phasic motion of the lung in vivo, ATP release into PCL was increased, CF ion transport was rebalanced, and PCL volume was restored to levels adequate for lung defense. This ATP signaling system was vulnerable, however, to insults that trigger CF bacterial infections, such as viral (respiratory syncitial virus) infections, which up-regulated extracellular ATPase activity and abolished motion-dependent ATP regulation of CF PCL height. These studies demonstrate (i) how the normal coordination of opposing ion transport pathways to maintain PCL volume is disrupted in CF, (ii) the hitherto unknown role of phasic motion in regulating key aspects of normal and CF innate airways defense, and (iii) that maneuvers directed at increasing motion-induced nucleotide release may be therapeutic in CF patients.The lung must continually defend itself against bacteria that deposit on airway surfaces during normal tidal breathing. It appears that mechanical clearance of bacteria mediated by mucus transport is the principal innate defense mechanism of mammalian airways (1-4). Recent data have shown that a critical component of this defense system is the thin (ϳ7) m liquid layer lining airway surfaces, the periciliary liquid (PCL), 2 that provides a low viscosity solution for ciliary beating and acts a lubricant layer for mucus transport (5, 6). In cystic fibrosis (CF) lung disease, it appears that the primary pathophysiologic defect is the depletion of PCL volume, resulting in a failure of mucus clearance of bacteria and persistent airways infection (7,8).However, questions have been raised as to the relevance of PCL depletion to CF pathogenesis in vivo (9). For example, whereas in vitro data from standard (static) culture systems describe rapid depletion of PCL height and a complete failure of mucus transport (7), young CF patients exhibit reduced but measurable rates of mucus clearance in vivo (10). This inconsistency suggests that mechanisms for PCL height regulation operating in vivo are absent from standard static culture systems. In addition, clinical observations suggest that CF lung disease exacerbates intermittently and is heterogeneous. Often, viral infections trigger these disease exacerbations (11, 12), but no links between viral infection and PCL regulation have been reported.To investigate these questions, we used a well differentiated airway epithelial culture system that exhibits PCL volume regulation and mucus transport (7). Ba...